Ignite Creation Date:
2024-05-06 @ 8:39 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02796352
Status:
TERMINATED
Last Update Posted:
2018-04-20
First Post:
2016-06-06
Brief Title:
A Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy Efficacy and Biomarker Study
Sponsor:
Ahmad Tarhini
Organization:
University of Pittsburgh
Organization Data
Organization:
University of Pittsburgh
Class:
OTHER
Study ID:
15-114
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ahmad Tarhini
Lead Sponsor Class:
OTHER
Responsible Party:
Ahmad Tarhini
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Pittsburgh
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Prometheus Laboratories | INDUSTRY |